Use of eINDs for evaluation of multiple related PET amyloid plaque imaging agents.
Avid Pharmaceuticals, Philadelphia, PA, USA.
Daniel
D
Skovronsky
D004341:Drug Evaluation / Q000592:standards*; D004345:Drug Industry / Q000592:standards; D015507:Drugs, Investigational / Q000592:standards*; D017408:Guidelines as Topic; D017387:Investigational New Drug Application / Q000458:organization & administration*; D058225:Plaque, Amyloid / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
D015507:Drugs, Investigational